| Aktie | Ticker | Breite | GCS | 2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 5.498.486.689 $ | +821.041.740 $ | -13,2 % | 118 | 5.396.779.685 $ | +1.222.923.198 $ | +49,9 % | 120 | 5.045.363.608 $ | +739.125.335 $ | +9,6 % | 109 | 4.899.391.958 $ | +846.358.491 $ | +25,1 % | 104 | |||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 630.050.775 $ | -465.555 $ | -0,1 % | 1 | 630.516.330 $ | +141.683.832 $ | +29,0 % | 1 | 488.832.498 $ | +103.741.119 $ | +26,9 % | 1 | 385.091.379 $ | +133.381.439 $ | +53,0 % | 1 |
| ADARx Pharmaceuticals, Inc. | ADRX | → 0 | Neutral | 482.663.433 $ | +482.663.433 $ | 1 | |||||||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 310.640.811 $ | -33.273.263 $ | -9,7 % | 1 | 343.914.074 $ | +31.900.184 $ | +10,2 % | 1 | 312.013.890 $ | +189.437.005 $ | +154,5 % | 1 | 122.576.885 $ | -40.354.858 $ | -24,8 % | 1 |
| ELI LILLY & Co | LLY | → 0 | Stark | 298.410.932 $ | -10.922.065 $ | -3,5 % | 1 | 309.332.997 $ | +91.531.461 $ | +42,0 % | 1 | 217.801.536 $ | -105.892.080 $ | -32,7 % | 1 | 323.693.616 $ | +93.878.016 $ | +40,8 % | 1 |
| MDxHealth SA | MDXH | → 0 | Schwach | 120.083 $ | +120.083 $ | 1 | 285.903.800 $ | +285.903.800 $ | 1 | ||||||||||
| Braveheart Bio, Inc. | BRVE | → 0 | 245.938.212 $ | +245.938.212 $ | 1 | ||||||||||||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Schwach | 63.302.976 $ | -86.173.799 $ | -57,7 % | 1 | 149.476.775 $ | -81.203.480 $ | -35,2 % | 1 | 230.680.255 $ | -26.018.304 $ | -10,1 % | 1 | ||||
| AVITA Medical, Inc. | RCEL | → 0 | Neutral | 196.958.309 $ | +196.958.309 $ | 1 | |||||||||||||
| SINOVAC BIOTECH LTD | SVA | → 0 | 195.500.000 $ | +11.033.830 $ | +6,0 % | 1 | 184.466.170 $ | +0 $ | +0,0 % | 1 | 184.466.170 $ | +0 $ | +0,0 % | 1 | 184.466.170 $ | +0 $ | +0,0 % | 1 | |
| MBX Biosciences, Inc. | MBX | → 0 | Neutral | 180.247.883 $ | -9.018.344 $ | -4,8 % | 1 | 189.266.227 $ | +80.675.300 $ | +74,3 % | 1 | 108.590.927 $ | -15.525.376 $ | -12,5 % | 1 | 124.116.303 $ | +54.065.780 $ | +77,2 % | 1 |
| ASTRAZENECA PLC | AZN | → 0 | Sehr stark | 61.782.783 $ | -109.296.719 $ | -63,9 % | 1 | 171.079.502 $ | +38.902.658 $ | +29,4 % | 1 | 132.176.844 $ | +132.176.844 $ | 1 | |||||
| Edwards Lifesciences Corp | EW | → 0 | Sehr stark | 72.068.568 $ | -3.456.486 $ | -4,6 % | 1 | 75.525.054 $ | -23.021.394 $ | -23,4 % | 1 | 98.546.448 $ | -71.348.277 $ | -42,0 % | 1 | 169.894.725 $ | +38.930.045 $ | +29,7 % | 1 |
| Upstream Bio, Inc. | UPB | → 0 | Neutral | 30.005.214 $ | -9.394.422 $ | -23,8 % | 1 | 39.399.636 $ | -11.842.665 $ | -23,1 % | 1 | 51.242.301 $ | -103.338.640 $ | -66,9 % | 1 | 154.580.941 $ | +47.484.532 $ | +44,3 % | 1 |
| INTUITIVE SURGICAL INC | ISRG | → 0 | Neutral | 39.361.784 $ | -23.431.888 $ | -37,3 % | 1 | 62.793.672 $ | -33.414.941 $ | -34,7 % | 1 | 96.208.613 $ | -52.970.611 $ | -35,5 % | 1 | 149.179.224 $ | +20.734.768 $ | +16,1 % | 1 |
| Sionna Therapeutics, Inc. | SION | → 0 | Neutral | 12.991.984 $ | -99.441.045 $ | -88,4 % | 1 | 112.433.029 $ | -29.112.814 $ | -20,6 % | 1 | 141.545.843 $ | -4.980.644 $ | -3,4 % | 1 | 146.526.487 $ | +37.563.643 $ | +34,5 % | 1 |
| Merck & Co., Inc. | MRK | → 0 | Stark | 137.477.791 $ | +52.230.891 $ | +61,3 % | 1 | 85.246.900 $ | +5.446.514 $ | +6,8 % | 1 | 79.800.386 $ | +79.800.386 $ | 1 | |||||
| MYRIAD GENETICS INC | MYGN | → 0 | Neutral | 122.875.000 $ | +122.875.000 $ | 1 | |||||||||||||
| ARGENX SE | ARGX | → 0 | Neutral | 72.090.854 $ | -14.080.424 $ | -16,3 % | 1 | 86.171.278 $ | -13.799.947 $ | -13,8 % | 1 | 99.971.225 $ | -22.807.475 $ | -18,6 % | 1 | 122.778.700 $ | -4.302.888 $ | -3,4 % | 1 |
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 41.620.370 $ | -76.958.128 $ | -64,9 % | 1 | 118.578.498 $ | +47.464.073 $ | +66,7 % | 1 | 71.114.425 $ | -9.688.974 $ | -12,0 % | 1 | 80.803.399 $ | +48.902.999 $ | +153,3 % | 1 |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | → 0 | Neutral | 5.117.510 $ | -34.256.020 $ | -87,0 % | 1 | 39.373.530 $ | -75.467.790 $ | -65,7 % | 1 | 114.841.320 $ | -22.688.280 $ | -16,5 % | 1 | ||||
| STRYKER CORP | SYK | → 0 | Neutral | 50.091.044 $ | -9.876.631 $ | -16,5 % | 1 | 59.967.675 $ | -54.260.075 $ | -47,5 % | 1 | 114.227.750 $ | -18.557.714 $ | -14,0 % | 1 | ||||
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 82.540.869 $ | -24.504.321 $ | -22,9 % | 1 | 107.045.190 $ | +2.221.152 $ | +2,1 % | 1 | 104.824.038 $ | +49.653.492 $ | +90,0 % | 1 | 55.170.546 $ | +2.364.452 $ | +4,5 % | 1 |
| ArriVent BioPharma, Inc. | AVBP | → 0 | Sehr schwach | 91.667.492 $ | -13.501.883 $ | -12,8 % | 1 | 105.169.375 $ | +35.328.918 $ | +50,6 % | 1 | 69.840.457 $ | +8.930.618 $ | +14,7 % | 1 | 60.909.839 $ | +5.055.637 $ | +9,1 % | 1 |
| Guardant Health, Inc. | GH | → 0 | Neutral | 104.180.076 $ | +16.607.565 $ | +19,0 % | 1 | 87.572.511 $ | +47.373.087 $ | +117,8 % | 1 | 40.199.424 $ | +40.199.424 $ | 1 | |||||
| Abivax S.A. | ABVX | → 0 | Neutral | 28.222.878 $ | -71.258.644 $ | -71,6 % | 1 | 99.481.522 $ | +47.625.827 $ | +91,8 % | 1 | 51.855.695 $ | +2.242.540 $ | +4,5 % | 1 | 49.613.155 $ | +17.351.155 $ | +53,8 % | 1 |
| ARS Pharmaceuticals, Inc. | SPRY | → 0 | Neutral | 35.723.478 $ | -30.667.487 $ | -46,2 % | 1 | 66.390.965 $ | -165.770 $ | -0,2 % | 1 | 66.556.735 $ | -30.004.407 $ | -31,1 % | 1 | 96.561.142 $ | +13.261.616 $ | +15,9 % | 1 |
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 86.993.320 $ | +30.195.408 $ | +53,2 % | 1 | |||||||||||||
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 26.150.110 $ | -42.109.037 $ | -61,7 % | 1 | 68.259.147 $ | -16.514.999 $ | -19,5 % | 1 | 84.774.146 $ | -8.730.376 $ | -9,3 % | 1 | ||||
| Caris Life Sciences, Inc. | CAI | → 0 | Schwach | 67.168.864 $ | +17.151.492 $ | +34,3 % | 1 | 50.017.372 $ | -168.409 $ | -0,3 % | 1 | 50.185.781 $ | -33.884.196 $ | -40,3 % | 1 | 84.069.977 $ | -7.734.478 $ | -8,4 % | 1 |
| Natera, Inc. | NTRA | → 0 | Neutral | 82.538.007 $ | +11.418.107 $ | +16,1 % | 1 | 71.119.900 $ | +18.722.520 $ | +35,7 % | 1 | 52.397.380 $ | -31.403.742 $ | -37,5 % | 1 | 83.801.122 $ | +14.696.701 $ | +21,3 % | 1 |
| uniQure N.V. | QURE | → 0 | Neutral | 19.593.760 $ | -63.659.045 $ | -76,5 % | 1 | 83.252.805 $ | +48.326.769 $ | +138,4 % | 1 | 34.926.036 $ | +17.280.054 $ | +97,9 % | 1 | 17.645.982 $ | -9.116.663 $ | -34,1 % | 1 |
| Arcutis Biotherapeutics, Inc. | ARQT | → 0 | Neutral | 82.517.103 $ | +28.975.863 $ | +54,1 % | 1 | 53.541.240 $ | +53.541.240 $ | 1 | |||||||||
| Compass Therapeutics, Inc. | CMPX | → 0 | Schwach | 15.828.794 $ | -17.502.993 $ | -52,5 % | 1 | 33.331.787 $ | -47.181.981 $ | -58,6 % | 1 | 80.513.768 $ | -1.217.600 $ | -1,5 % | 1 | 81.731.368 $ | +28.461.389 $ | +53,4 % | 1 |
| THERMO FISHER SCIENTIFIC INC. | TMO | → 0 | Neutral | 81.276.020 $ | +35.802.668 $ | +78,7 % | 1 | 45.473.352 $ | +22.617.207 $ | +99,0 % | 1 | 22.856.145 $ | -4.088.280 $ | -15,2 % | 1 | 26.944.425 $ | +4.390.995 $ | +19,5 % | 1 |
| UNITEDHEALTH GROUP INC | UNH | → 0 | Sehr stark | 80.390.520 $ | +9.276.227 $ | +13,0 % | 1 | 71.114.293 $ | +71.114.293 $ | 1 | |||||||||
| Ascendis Pharma A/S | ASND | → 0 | Stark | 78.646.916 $ | +13.445.612 $ | +20,6 % | 1 | 65.201.304 $ | +23.577.705 $ | +56,6 % | 1 | 41.623.599 $ | +4.951.224 $ | +13,5 % | 1 | 36.672.375 $ | -1.480.258 $ | -3,9 % | 1 |
| Electra Therapeutics, Inc. | ETRA | → 0 | Neutral | 77.458.163 $ | +77.458.163 $ | 1 | |||||||||||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 58.362.492 $ | -18.672.687 $ | -24,2 % | 1 | 77.035.179 $ | +21.457.404 $ | +38,6 % | 1 | 55.577.775 $ | +27.724.845 $ | +99,5 % | 1 | 27.852.930 $ | +27.852.930 $ | 1 | |
| Travere Therapeutics, Inc. | TVTX | → 0 | Neutral | 76.625.724 $ | +56.358.444 $ | +278,1 % | 1 | 20.267.280 $ | +20.267.280 $ | 1 | |||||||||
| Prelude Therapeutics Inc | PRLD | → 0 | Stark | 53.663.073 $ | -19.488.890 $ | -26,6 % | 1 | 73.151.963 $ | +35.842.307 $ | +96,1 % | 1 | 37.309.656 $ | +5.672.814 $ | +17,9 % | 1 | 31.636.842 $ | +15.927.513 $ | +101,4 % | 1 |
| Tango Therapeutics, Inc. | TNGX | → 0 | Schwach | 73.044.144 $ | +73.044.144 $ | 1 | |||||||||||||
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 71.864.542 $ | +18.963.305 $ | +35,8 % | 1 | 52.901.237 $ | +9.826.518 $ | +22,8 % | 1 | 43.074.719 $ | +13.800.291 $ | +47,1 % | 1 | ||||
| CG Oncology, Inc. | CGON | → 0 | Neutral | 69.117.440 $ | +4.938.729 $ | +7,7 % | 1 | 64.178.711 $ | +1.211.555 $ | +1,9 % | 1 | 62.967.156 $ | -6.590.362 $ | -9,5 % | 1 | ||||
| DANAHER CORP /DE/ | DHR | → 0 | Neutral | 4.120.830 $ | +4.120.830 $ | 1 | 50.395.680 $ | -18.234.536 $ | -26,6 % | 1 | 68.630.216 $ | +16.468.010 $ | +31,6 % | 1 | |||||
| AbbVie Inc. | ABBV | → 0 | Neutral | 67.908.764 $ | +67.908.764 $ | 1 | |||||||||||||
| Odyssey Therapeutics, Inc. | ODTX | → 0 | Neutral | 66.686.620 $ | +10.534.205 $ | +18,8 % | 1 | 56.152.415 $ | +56.152.415 $ | 1 | |||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 64.158.474 $ | -2.135.336 $ | -3,2 % | 1 | 66.293.810 $ | +52.676.181 $ | +386,8 % | 1 | 13.617.629 $ | -734.391 $ | -5,1 % | 1 | 14.352.020 $ | +14.352.020 $ | 1 | |
| HUMANA INC | HUM | → 0 | Neutral | 48.764.646 $ | -16.419.156 $ | -25,2 % | 1 | 65.183.802 $ | +65.183.802 $ | 1 | |||||||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Schwach | 53.869.550 $ | -7.767.764 $ | -12,6 % | 1 | 61.637.314 $ | +41.593.810 $ | +207,5 % | 1 | 20.043.504 $ | +3.196.564 $ | +19,0 % | 1 | ||||
| Apellis Pharmaceuticals, Inc. | APLS | → 0 | 61.038.284 $ | +2.802.966 $ | +4,8 % | 1 | |||||||||||||
| CareDx, Inc. | CDNA | → 0 | Neutral | 60.762.000 $ | +60.762.000 $ | 1 | |||||||||||||
| ABBOTT LABORATORIES | ABT | → 0 | Neutral | 57.222.570 $ | +57.222.570 $ | 1 | |||||||||||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Schwach | 36.553.394 $ | -20.382.500 $ | -35,8 % | 1 | 56.935.894 $ | +1.322.833 $ | +2,4 % | 1 | 55.613.061 $ | +20.034.345 $ | +56,3 % | 1 | 35.578.716 $ | -20.144.496 $ | -36,2 % | 1 |
| Cigna Group | CI | → 0 | Sehr stark | 56.422.150 $ | +9.495.050 $ | +20,2 % | 1 | ||||||||||||
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Stark | 53.298.500 $ | -2.802.750 $ | -5,0 % | 1 | 56.101.250 $ | +14.297.750 $ | +34,2 % | 1 | 41.803.500 $ | +41.803.500 $ | 1 | |||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 55.644.718 $ | +27.620.840 $ | +98,6 % | 1 | |||||||||||||
| PFIZER INC | PFE | → 0 | Neutral | 54.657.720 $ | +13.500.510 $ | +32,8 % | 1 | 41.157.210 $ | +28.417.210 $ | +223,1 % | 1 | ||||||||
| Q32 Bio Inc. | QTTB | → 0 | Neutral | 34.138.452 $ | -18.452.102 $ | -35,1 % | 1 | 52.590.554 $ | +38.126.377 $ | +263,6 % | 1 | 14.464.177 $ | +6.984.260 $ | +93,4 % | 1 | 7.479.917 $ | +3.019.003 $ | +67,7 % | 1 |
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Stark | 51.258.700 $ | +3.091.471 $ | +6,4 % | 1 | ||||||||||||
| PALVELLA THERAPEUTICS, INC. | PVLA | → 0 | Neutral | 31.704.590 $ | -19.086.665 $ | -37,6 % | 1 | 50.791.255 $ | +27.780.865 $ | +120,7 % | 1 | 23.010.390 $ | +23.010.390 $ | 1 | |||||
| BlossomHill Therapeutics, Inc. | BLSM | → 0 | 50.594.161 $ | +50.594.161 $ | 1 | ||||||||||||||
| Elevance Health, Inc. | ELV | → 0 | Stark | 48.225.231 $ | +14.646.806 $ | +43,6 % | 1 | 33.578.425 $ | -1.161.080 $ | -3,3 % | 1 | 34.739.505 $ | +34.739.505 $ | 1 | |||||
| Roivant Sciences Ltd. | ROIV | → 0 | Neutral | 47.542.682 $ | +6.467.788 $ | +15,7 % | 1 | ||||||||||||
| SPDR SERIES TRUST | → 0 | 47.475.000 $ | +47.475.000 $ | 1 | |||||||||||||||
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | 37.382.580 $ | +1.098.900 $ | +3,0 % | 1 | 36.283.680 $ | -10.219.770 $ | -22,0 % | 1 | 46.503.450 $ | -3.434.900 $ | -6,9 % | 1 | |||||
| Axsome Therapeutics, Inc. | AXSM | → 0 | Neutral | 31.508.194 $ | +2.728.627 $ | +9,5 % | 1 | 28.779.567 $ | -7.377.360 $ | -20,4 % | 1 | 36.156.927 $ | -10.073.092 $ | -21,8 % | 1 | 46.230.019 $ | -18.357.091 $ | -28,4 % | 1 |
| EyePoint, Inc. | EYPT | → 0 | Sehr schwach | 2.418.790 $ | -12.870.012 $ | -84,2 % | 1 | 15.288.802 $ | +1.507.497 $ | +10,9 % | 1 | 13.781.305 $ | -31.314.792 $ | -69,4 % | 1 | 45.096.097 $ | +19.521.057 $ | +76,3 % | 1 |
| Avidity Biosciences, Inc. | RNA | → 0 | 44.686.699 $ | -26.719.564 $ | -37,4 % | 1 | |||||||||||||
| NEUROCRINE BIOSCIENCES INC | NBIX | → 0 | Stark | 44.568.659 $ | -5.075.324 $ | -10,2 % | 1 | ||||||||||||
| Shattuck Labs, Inc. | STTK | → 0 | Neutral | 43.007.786 $ | -756.735 $ | -1,7 % | 1 | 43.764.521 $ | +3.216.124 $ | +7,9 % | 1 | 40.548.397 $ | +17.531.033 $ | +76,2 % | 1 | 23.017.364 $ | +7.945.720 $ | +52,7 % | 1 |
| UroGen Pharma Ltd. | URGN | → 0 | Schwach | 40.162.227 $ | +15.278.545 $ | +61,4 % | 1 | 24.883.682 $ | +9.142.426 $ | +58,1 % | 1 | 15.741.256 $ | -4.762.650 $ | -23,2 % | 1 | 20.503.906 $ | +6.758.356 $ | +49,2 % | 1 |
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 13.823.096 $ | -12.851.868 $ | -48,2 % | 1 | 26.674.964 $ | -2.606.028 $ | -8,9 % | 1 | 29.280.992 $ | -10.666.572 $ | -26,7 % | 1 | 39.947.564 $ | +9.675.704 $ | +32,0 % | 1 |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Schwach | 38.847.720 $ | +2.996.133 $ | +8,4 % | 1 | 35.851.587 $ | +8.534.310 $ | +31,2 % | 1 | 27.317.277 $ | +1.649.085 $ | +6,4 % | 1 | 25.668.192 $ | +3.939.992 $ | +18,1 % | 1 |
| NeuroPace Inc | NPCE | → 0 | Sehr schwach | 14.518.520 $ | -9.397.916 $ | -39,3 % | 1 | 23.916.436 $ | -3.652.894 $ | -13,2 % | 1 | 27.569.330 $ | -9.584.482 $ | -25,8 % | 1 | 37.153.812 $ | +10.201.575 $ | +37,9 % | 1 |
| EXACT SCIENCES CORP | EXAS | → 0 | 35.720.277 $ | -18.695.164 $ | -34,4 % | 1 | |||||||||||||
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Neutral | 20.957.973 $ | -864.477 $ | -4,0 % | 1 | 21.822.450 $ | -12.309.630 $ | -36,1 % | 1 | 34.132.080 $ | +4.342.516 $ | +14,6 % | 1 | 29.789.564 $ | -13.911.508 $ | -31,8 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Sehr schwach | 33.708.120 $ | +11.228.792 $ | +50,0 % | 1 | 22.479.328 $ | +22.479.328 $ | 1 | |||||||||
| Forte Biosciences, Inc. | FBRX | → 0 | 33.526.231 $ | +2.525.096 $ | +8,1 % | 1 | 31.001.135 $ | -1.639.828 $ | -5,0 % | 1 | 32.640.963 $ | +14.686.638 $ | +81,8 % | 1 | |||||
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 6.296.198 $ | -18.831.671 $ | -74,9 % | 1 | 25.127.869 $ | -7.694.544 $ | -23,4 % | 1 | 32.822.413 $ | +20.213.215 $ | +160,3 % | 1 | 12.609.198 $ | +12.609.198 $ | 1 | |
| Krystal Biotech, Inc. | KRYS | → 0 | Sehr stark | 32.491.112 $ | +1.568.168 $ | +5,1 % | 1 | 30.922.944 $ | +13.073.032 $ | +73,2 % | 1 | 17.849.912 $ | -11.685.580 $ | -39,6 % | 1 | 29.535.492 $ | +11.397.917 $ | +62,8 % | 1 |
| NEKTAR THERAPEUTICS | NKTR | → 0 | Schwach | 23.280.763 $ | -9.205.041 $ | -28,3 % | 1 | 32.485.804 $ | +12.699.554 $ | +64,2 % | 1 | 19.786.250 $ | +19.786.250 $ | 1 | |||||
| Helus Pharma Inc. | HELP | → 0 | Neutral | 21.623.954 $ | +3.226.308 $ | +17,5 % | 1 | 18.397.646 $ | -13.017.644 $ | -41,4 % | 1 | 31.415.290 $ | +31.415.290 $ | 1 | |||||
| Jazz Pharmaceuticals plc | JAZZ | → 0 | Neutral | 30.352.272 $ | +30.352.272 $ | 1 | |||||||||||||
| BERKSHIRE HATHAWAY INC | BRK-B | → 0 | Stark | 22.209.527 $ | -8.065.864 $ | -26,6 % | 1 | 30.275.391 $ | +8.195.590 $ | +37,1 % | 1 | 22.079.801 $ | +1.945.342 $ | +9,7 % | 1 | 20.134.459 $ | +7.629.680 $ | +61,0 % | 1 |
| WEST PHARMACEUTICAL SERVICES INC | WST | → 0 | Stark | 29.727.537 $ | +4.382.137 $ | +17,3 % | 1 | 25.345.400 $ | +25.345.400 $ | 1 | |||||||||
| Esperion Therapeutics, Inc. | ESPR | → 0 | 28.962.622 $ | +6.890.279 $ | +31,2 % | 1 | 22.072.343 $ | +22.072.343 $ | 1 | ||||||||||
| Latigo Biotherapeutics, Inc. | LTGO | → 0 | 27.977.777 $ | +27.977.777 $ | 1 | ||||||||||||||
| Janux Therapeutics, Inc. | JANX | → 0 | Sehr schwach | 9.066.816 $ | +1.007.424 $ | +12,5 % | 1 | 8.059.392 $ | -5.612.648 $ | -41,1 % | 1 | 13.672.040 $ | -13.299.039 $ | -49,3 % | 1 | 26.971.079 $ | -16.192.405 $ | -37,5 % | 1 |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 25.145.065 $ | -1.801.900 $ | -6,7 % | 1 | 26.946.965 $ | +21.889.965 $ | +432,9 % | 1 | 5.057.000 $ | +2.994.065 $ | +145,1 % | 1 | 2.062.935 $ | +2.062.935 $ | 1 | |
| Kiniksa Pharmaceuticals International, plc | KNSA | → 0 | Stark | 17.824.329 $ | -9.073.041 $ | -33,7 % | 1 | 26.897.370 $ | +18.201.528 $ | +209,3 % | 1 | 8.695.842 $ | +973.883 $ | +12,6 % | 1 | 7.721.959 $ | +7.721.959 $ | 1 | |
| BRUKER CORP | BRKR | → 0 | Neutral | 3.133.900 $ | +3.133.900 $ | 1 | 26.183.220 $ | +26.183.220 $ | 1 | ||||||||||
| Celcuity Inc. | CELC | → 0 | Neutral | 25.009.040 $ | +25.009.040 $ | 1 | 8.544.127 $ | +1.709.299 $ | +25,0 % | 1 | |||||||||
| Scribe Therapeutics, Inc. | SCTX | → 0 | Schwach | 24.825.124 $ | +24.825.124 $ | 1 | |||||||||||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 11.984.938 $ | -12.714.003 $ | -51,5 % | 1 | 24.698.941 $ | +4.742.444 $ | +23,8 % | 1 | 19.956.497 $ | +19.956.497 $ | 1 | |||||
| Savara Inc | SVRA | → 0 | Schwach | 20.433.084 $ | -3.959.900 $ | -16,2 % | 1 | 24.392.984 $ | +20.925.884 $ | +603,6 % | 1 | 3.467.100 $ | +3.467.100 $ | 1 | |||||
| DEXCOM INC | DXCM | → 0 | Neutral | 23.988.620 $ | +23.988.620 $ | 1 | |||||||||||||
| Aura Biosciences, Inc. | AURA | → 0 | Neutral | 20.933.331 $ | -2.733.333 $ | -11,5 % | 1 | 23.666.664 $ | +23.666.664 $ | 1 | |||||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 21.133.500 $ | -2.414.118 $ | -10,3 % | 1 | 23.547.618 $ | +19.110.278 $ | +430,7 % | 1 | 4.437.340 $ | +2.542.062 $ | +134,1 % | 1 | 1.895.278 $ | +1.895.278 $ | 1 | |
| Vogenx, Inc. | VOGX | → 0 | 22.074.873 $ | +22.074.873 $ | 1 | ||||||||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Neutral | 7.094.213 $ | -14.467.155 $ | -67,1 % | 1 | 21.561.368 $ | +4.411.765 $ | +25,7 % | 1 | ||||||||
| BrightSpring Health Services, Inc. | BTSG | → 0 | Neutral | 21.211.258 $ | +2.916.933 $ | +15,9 % | 1 | 18.294.325 $ | +6.062.397 $ | +49,6 % | 1 | ||||||||
| Lexeo Therapeutics, Inc. | LXEO | → 0 | Neutral | 10.826.309 $ | -7.550.933 $ | -41,1 % | 1 | 18.377.242 $ | -2.300.821 $ | -11,1 % | 1 | 20.678.063 $ | -423.187 $ | -2,0 % | 1 | 21.101.250 $ | +21.101.250 $ | 1 | |
| ADC Therapeutics SA | ADCT | → 0 | Neutral | 4.942.598 $ | -15.612.077 $ | -76,0 % | 1 | 20.554.675 $ | -3.074.729 $ | -13,0 % | 1 | ||||||||
| Apnimed, Inc. | APMD | → 0 | 20.266.750 $ | +20.266.750 $ | 1 | ||||||||||||||
| Immatics N.V. | IMTX | → 0 | Neutral | 19.587.644 $ | +19.587.644 $ | 1 | |||||||||||||
| Pyxis Oncology, Inc. | PYXS | → 0 | Schwach | 19.483.267 $ | +19.483.267 $ | 1 | |||||||||||||
| ACHIEVE LIFE SCIENCES, INC. | ACHV | → 0 | Neutral | 18.964.578 $ | +18.964.578 $ | 1 | |||||||||||||
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 14.627.480 $ | -3.892.520 $ | -21,0 % | 1 | 18.520.000 $ | +4.952.096 $ | +36,5 % | 1 | 13.567.904 $ | -18.136 $ | -0,1 % | 1 | 13.586.040 $ | +6.743.655 $ | +98,6 % | 1 |
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 5.046.740 $ | -13.388.530 $ | -72,6 % | 1 | 18.435.270 $ | +5.985.696 $ | +48,1 % | 1 | 12.449.574 $ | +1.985.954 $ | +19,0 % | 1 | 10.463.620 $ | +5.813.122 $ | +125,0 % | 1 |
| Whitehawk Therapeutics, Inc. | WHWK | → 0 | Stark | 14.489.055 $ | -3.530.021 $ | -19,6 % | 1 | 18.019.076 $ | +3.646.376 $ | +25,4 % | 1 | 14.372.700 $ | +4.290.980 $ | +42,6 % | 1 | 10.081.720 $ | +2.166.320 $ | +27,4 % | 1 |
| BIOGEN INC. | BIIB | → 0 | Stark | 17.934.872 $ | +4.625.576 $ | +34,8 % | 1 | 13.309.296 $ | +2.016.168 $ | +17,9 % | 1 | 11.293.128 $ | +11.293.128 $ | 1 | |||||
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 15.859.364 $ | +990.517 $ | +6,7 % | 1 | 14.868.847 $ | -3.032.393 $ | -16,9 % | 1 | 17.901.240 $ | +17.901.240 $ | 1 | |||||
| WATERS CORP /DE/ | WAT | → 0 | Stark | 17.707.417 $ | +2.593.305 $ | +17,2 % | 1 | 15.114.112 $ | +15.114.112 $ | 1 | |||||||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Neutral | 16.894.834 $ | -293.582 $ | -1,7 % | 1 | 17.188.416 $ | +1.992.816 $ | +13,1 % | 1 | 15.195.600 $ | -1.229.913 $ | -7,5 % | 1 | 16.425.513 $ | +12.088.868 $ | +278,8 % | 1 |
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 4.213.434 $ | -12.312.519 $ | -74,5 % | 1 | 16.525.953 $ | +16.525.953 $ | 1 | |||||||||
| Keros Therapeutics, Inc. | KROS | → 0 | Sehr stark | 8.654.367 $ | +531.408 $ | +6,5 % | 1 | 8.122.959 $ | -258.112 $ | -3,1 % | 1 | 8.381.071 $ | -7.992.685 $ | -48,8 % | 1 | 16.373.756 $ | +257.384 $ | +1,6 % | 1 |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Neutral | 16.367.050 $ | +16.367.050 $ | 1 | |||||||||||||
| Corbus Pharmaceuticals Holdings, Inc. | CRBP | → 0 | Neutral | 11.359.774 $ | -4.935.978 $ | -30,3 % | 1 | 16.295.752 $ | -17.373 $ | -0,1 % | 1 | 16.313.125 $ | +3.311.209 $ | +25,5 % | 1 | 13.001.916 $ | -1.827.515 $ | -12,3 % | 1 |
| CVS HEALTH Corp | CVS | → 0 | Stark | 15.646.994 $ | +15.646.994 $ | 1 | |||||||||||||
| CARLSMED, INC. | CARL | → 0 | Neutral | 11.336.030 $ | -4.133.580 $ | -26,7 % | 1 | 15.469.610 $ | -1.302.704 $ | -7,8 % | 1 | ||||||||
| ALUMIS INC. | ALMS | → 0 | Neutral | 4.050.925 $ | -11.374.382 $ | -73,7 % | 1 | 15.425.307 $ | +3.349.276 $ | +27,7 % | 1 | 12.076.031 $ | +1.313.386 $ | +12,2 % | 1 | 10.762.645 $ | +3.076.217 $ | +40,0 % | 1 |
| CytomX Therapeutics, Inc. | CTMX | → 0 | Neutral | 15.019.269 $ | -11.972.916 $ | -44,4 % | 1 | ||||||||||||
| Monopar Therapeutics | MNPR | → 0 | Neutral | 14.575.796 $ | +14.575.796 $ | 1 | |||||||||||||
| Vir Biotechnology, Inc. | VIR | → 0 | Sehr schwach | 14.355.711 $ | +761.828 $ | +5,6 % | 1 | ||||||||||||
| AMGEN INC | AMGN | → 0 | Neutral | 14.038.815 $ | +14.038.815 $ | 1 | |||||||||||||
| Alignment Healthcare, Inc. | ALHC | → 0 | Neutral | 13.937.420 $ | +13.937.420 $ | 1 | |||||||||||||
| VERTEX PHARMACEUTICALS INC / MA | VRTX | → 0 | Neutral | 13.697.622 $ | +13.697.622 $ | 1 | |||||||||||||
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 9.740.000 $ | -3.880.000 $ | -28,5 % | 1 | 13.620.000 $ | +13.620.000 $ | 1 | |||||||||
| Bicara Therapeutics Inc. | BCAX | → 0 | Neutral | 5.673.759 $ | -7.598.838 $ | -57,3 % | 1 | 13.272.597 $ | +9.753.444 $ | +277,2 % | 1 | 3.519.153 $ | +3.519.153 $ | 1 | |||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 12.716.935 $ | +12.716.935 $ | 1 | |||||||||||||
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Neutral | 2.719.906 $ | +480.438 $ | +21,5 % | 1 | 2.239.468 $ | +2.239.468 $ | 1 | 12.642.272 $ | +881.075 $ | +7,5 % | 1 | |||||
| Tectonic Therapeutic, Inc. | TECX | → 0 | Neutral | 3.868.516 $ | -3.920.859 $ | -50,3 % | 1 | 7.789.375 $ | +785.169 $ | +11,2 % | 1 | 7.004.206 $ | -4.981.950 $ | -41,6 % | 1 | 11.986.156 $ | +11.986.156 $ | 1 | |
| Erasca, Inc. | ERAS | → 0 | Neutral | 11.815.960 $ | +2.731.072 $ | +30,1 % | 1 | 9.084.888 $ | +9.084.888 $ | 1 | |||||||||
| SPRUCE BIOSCIENCES, INC. | SPRB | → 0 | Neutral | 11.795.224 $ | +995.224 $ | +9,2 % | 1 | 10.800.000 $ | +10.800.000 $ | 1 | |||||||||
| REGENERON PHARMACEUTICALS, INC. | REGN | → 0 | Stark | 11.357.808 $ | +11.357.808 $ | 1 | |||||||||||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 3.724.515 $ | -7.485.685 $ | -66,8 % | 1 | 11.210.200 $ | +11.210.200 $ | 1 | |||||||||
| AMICUS THERAPEUTICS, INC. | FOLD | → 0 | 10.393.776 $ | -2.571.976 $ | -19,8 % | 1 | |||||||||||||
| LifeStance Health Group, Inc. | LFST | → 0 | Neutral | 10.146.654 $ | +6.961.654 $ | +218,6 % | 1 | 3.185.000 $ | +3.185.000 $ | 1 | |||||||||
| QIAGEN N.V. | QGEN | → 0 | Neutral | 10.010.000 $ | +10.010.000 $ | 1 | |||||||||||||
| Adicet Bio, Inc. | ACET | → 0 | Schwach | 6.031.779 $ | -1.267.181 $ | -17,4 % | 1 | 7.298.960 $ | +298.661 $ | +4,3 % | 1 | 7.000.299 $ | -1.654.989 $ | -19,1 % | 1 | 8.655.288 $ | -619.185 $ | -6,7 % | 1 |
| Repare Therapeutics Inc. | → 0 | 8.638.469 $ | +2.790.890 $ | +47,7 % | 1 | ||||||||||||||
| Protara Therapeutics, Inc. | TARA | → 0 | Schwach | 8.480.400 $ | +8.480.400 $ | 1 | |||||||||||||
| GILEAD SCIENCES, INC. | GILD | → 0 | Neutral | 8.306.452 $ | +8.306.452 $ | 1 | |||||||||||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 2.599.405 $ | -5.596.440 $ | -68,3 % | 1 | 8.195.845 $ | +3.611.908 $ | +78,8 % | 1 | ||||||||
| HERON THERAPEUTICS, INC. /DE/ | HRTX | → 0 | Schwach | 7.854.534 $ | +7.854.534 $ | 1 | |||||||||||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 7.102.732 $ | +1.300.182 $ | +22,4 % | 1 | 5.802.550 $ | +102.700 $ | +1,8 % | 1 | 5.699.850 $ | +5.699.850 $ | 1 | |||||
| Alto Neuroscience, Inc. | ANRO | → 0 | Neutral | 6.804.714 $ | +3.039.314 $ | +80,7 % | 1 | 3.765.400 $ | +1.540.400 $ | +69,2 % | 1 | 2.225.000 $ | +1.220.000 $ | +121,4 % | 1 | ||||
| Zentalis Pharmaceuticals, Inc. | ZNTL | → 0 | Schwach | 3.643.533 $ | -3.100.761 $ | -46,0 % | 1 | 6.744.294 $ | +6.744.294 $ | 1 | |||||||||
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Schwach | 4.035.420 $ | -2.493.180 $ | -38,2 % | 1 | 6.528.600 $ | +3.609.800 $ | +123,7 % | 1 | 2.918.800 $ | +2.918.800 $ | 1 | |||||
| COMPASS Pathways plc | CMPS | → 0 | Schwach | 6.363.072 $ | +6.363.072 $ | 1 | |||||||||||||
| PMV Pharmaceuticals, Inc. | PMVP | → 0 | Neutral | 6.219.114 $ | -2.146.293 $ | -25,7 % | 1 | ||||||||||||
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 1.900.272 $ | -4.275.488 $ | -69,2 % | 1 | 6.175.760 $ | +6.175.760 $ | 1 | ||||||||||
| Yarrow Bioscience, Inc. | YARW | → 0 | Schwach | 5.997.211 $ | +5.997.211 $ | 1 | |||||||||||||
| ALX ONCOLOGY HOLDINGS INC | ALXO | → 0 | Stark | 3.812.726 $ | -2.120.424 $ | -35,7 % | 1 | 5.933.150 $ | +186.307 $ | +3,2 % | 1 | 5.746.843 $ | +5.746.843 $ | 1 | |||||
| Xilio Therapeutics, Inc. | XLO | → 0 | 5.360.315 $ | -313.919 $ | -5,5 % | 1 | 5.674.234 $ | +5.674.234 $ | 1 | ||||||||||
| InspireMD, Inc. | NSPR | → 0 | Neutral | 2.092.488 $ | -101.209 $ | -4,6 % | 1 | 2.193.697 $ | -2.913.753 $ | -57,0 % | 1 | 5.107.450 $ | -470.011 $ | -8,4 % | 1 | 5.577.461 $ | +435.955 $ | +8,5 % | 1 |
| ARTIVION, INC. | AORT | → 0 | Neutral | 3.993.500 $ | +61.250 $ | +1,6 % | 1 | 3.932.250 $ | -1.597.370 $ | -28,9 % | 1 | 5.529.620 $ | +5.529.620 $ | 1 | |||||
| ImageneBio, Inc. | IMA | → 0 | 4.164.452 $ | -1.200.235 $ | -22,4 % | 1 | 5.364.687 $ | +3.471.907 $ | +183,4 % | 1 | 1.892.780 $ | -719.256 $ | -27,5 % | 1 | 2.612.036 $ | -473.195 $ | -15,3 % | 1 | |
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 4.875.970 $ | +793.220 $ | +19,4 % | 1 | 4.082.750 $ | -315.087 $ | -7,2 % | 1 | 4.397.837 $ | +4.397.837 $ | 1 | |||||
| IMMUNIC, INC. | IMUX | → 0 | Neutral | 4.424.977 $ | +4.424.977 $ | 1 | |||||||||||||
| INSMED Inc | INSM | → 0 | Schwach | 4.420.616 $ | +2.482.385 $ | +128,1 % | 1 | ||||||||||||
| AtaiBeckley Inc. | ATAI | → 0 | 4.202.825 $ | +2.974.445 $ | +242,1 % | 1 | 1.228.380 $ | +1.228.380 $ | 1 | ||||||||||
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Schwach | 4.031.680 $ | +4.031.680 $ | 1 | |||||||||||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Sehr stark | 3.180.698 $ | -824.389 $ | -20,6 % | 1 | 4.005.087 $ | +659.904 $ | +19,7 % | 1 | 3.345.183 $ | +1.582.911 $ | +89,8 % | 1 | 1.762.272 $ | +1.762.272 $ | 1 | |
| Neumora Therapeutics, Inc. | NMRA | → 0 | Schwach | 3.637.799 $ | +3.637.799 $ | 1 | |||||||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 3.466.100 $ | +3.466.100 $ | 1 | |||||||||||||
| Cullinan Therapeutics, Inc. | CGEM | → 0 | Neutral | 3.453.115 $ | +658.553 $ | +23,6 % | 1 | 2.794.562 $ | -8.613.898 $ | -75,5 % | 1 | ||||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 3.348.000 $ | +3.348.000 $ | 1 | ||||||||||||||
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Neutral | 3.293.864 $ | +3.293.864 $ | 1 | |||||||||||||
| BIOMARIN PHARMACEUTICAL INC | BMRN | → 0 | Neutral | 3.258.000 $ | +3.258.000 $ | 1 | |||||||||||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 3.257.880 $ | +3.257.880 $ | 1 | |||||||||||||
| Rapport Therapeutics, Inc. | RAPP | → 0 | Neutral | 3.192.589 $ | +3.192.589 $ | 1 | |||||||||||||
| C4 Therapeutics, Inc. | CCCC | → 0 | Neutral | 2.252.208 $ | -431.155 $ | -16,1 % | 1 | 2.683.363 $ | -8.938.661 $ | -76,9 % | 1 | ||||||||
| AgomAb Therapeutics NV | AGMB | → 0 | Neutral | 2.501.765 $ | +2.501.765 $ | 1 | |||||||||||||
| BELITE BIO, INC | BLTE | → 0 | Neutral | 2.258.606 $ | +210.605 $ | +10,3 % | 1 | 2.048.001 $ | +2.048.001 $ | 1 | |||||||||
| Aclaris Therapeutics, Inc. | ACRS | → 0 | Schwach | 2.229.735 $ | +2.229.735 $ | 1 | |||||||||||||
| CYTOKINETICS INC | CYTK | → 0 | Neutral | 2.197.902 $ | +2.197.902 $ | 1 | |||||||||||||
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Schwach | 1.687.400 $ | -473.000 $ | -21,9 % | 1 | 2.160.400 $ | +2.160.400 $ | 1 | 1.909.622 $ | +1.909.622 $ | 1 | ||||||
| Evommune, Inc. | EVMN | → 0 | Neutral | 1.329.860 $ | -809.830 $ | -37,8 % | 1 | 2.139.690 $ | +2.139.690 $ | 1 | |||||||||
| Vistagen Therapeutics, Inc. | VTGN | → 0 | 1.748.790 $ | -306.542 $ | -14,9 % | 1 | 2.055.332 $ | -8.968.128 $ | -81,4 % | 1 | |||||||||
| Ovid Therapeutics Inc. | OVID | → 0 | Neutral | 2.009.430 $ | +2.009.430 $ | 1 | |||||||||||||
| Unicycive Therapeutics, Inc. | UNCY | → 0 | Schwach | 1.816.965 $ | +1.816.965 $ | 1 | |||||||||||||
| EUPRAXIA PHARMACEUTICALS INC. | EPRX | → 0 | Neutral | 1.771.952 $ | -6.138 $ | -0,3 % | 1 | 1.778.090 $ | +1.778.090 $ | 1 | |||||||||
| SELLAS Life Sciences Group, Inc. | SLS | → 0 | Neutral | 1.231.000 $ | -134.300 $ | -9,8 % | 1 | 1.365.300 $ | +1.365.300 $ | 1 | |||||||||
| Ginkgo Bioworks Holdings, Inc. | DNA | → 0 | Schwach | 1.283.000 $ | +1.283.000 $ | 1 | |||||||||||||
| Traws Pharma, Inc. | TRAW | → 0 | 714.496 $ | -300.213 $ | -29,6 % | 1 | 1.014.709 $ | -93.413 $ | -8,4 % | 1 | 1.108.122 $ | +423.872 $ | +61,9 % | 1 | 684.250 $ | -435.982 $ | -38,9 % | 1 | |
| VIRIDIAN THERAPEUTICS INC | → 0 | 1.072.670 $ | +1.072.670 $ | 1 | |||||||||||||||
| MapLight Therapeutics, Inc. | MPLT | → 0 | Neutral | 952.000 $ | +952.000 $ | 1 | |||||||||||||
| Gesamt | 5.498.486.689 $ | +821.041.740 $ | -13,2 % | 118 | 5.396.779.685 $ | +1.222.923.198 $ | +49,9 % | 120 | 5.045.363.608 $ | +739.125.335 $ | +9,6 % | 109 | 4.899.391.958 $ | +846.358.491 $ | +25,1 % | 104 | |||
Keine Anlageberatung, keine individuelle Empfehlung.
Der Glück Conviction Score und die daraus abgeleiteten Einstufungen und Hinweise sind das Ergebnis eines
überwiegend regelbasierten Scoring-Modells aus öffentlich verfügbaren Daten (SEC-Filings,
Fundamentaldaten, Kursdaten). Sie richten sich an ein breites Publikum und
berücksichtigen keine persönlichen Verhältnisse, Anlageziele oder Risikobereitschaften.
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 20.11.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 20.11.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.
Keine Anlageberatung, keine individuelle Empfehlung.
Der Glück Conviction Score ist das Ergebnis eines überwiegend regelbasierten Scoring-Modells aus öffentlich
verfügbaren Daten. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.